Fast filtration enzyme immunoassay for haptens

Area of Science:

• Biochemistry
• Analytical Chemistry
• Immunology

Background:

• Accurate quantification of therapeutic drugs in biological fluids is crucial for effective patient treatment.
• Existing methods for drug concentration determination can be time-consuming or require complex instrumentation.
• Development of rapid and sensitive assays is needed for point-of-care diagnostics.

Purpose of the Study:

• To develop a novel immunometric method for the rapid and accurate determination of hapten concentrations in biological samples.
• To validate the assay for specific therapeutic drugs, including theophylline, digoxin, and phenobarbital.
• To assess the assay's precision and speed for clinical applicability.

Main Methods:

• An immunometric assay utilizing high-affinity, hapten-specific, enzyme-labeled monoclonal antibodies.
• Sample incubation with enzyme-labeled antibodies followed by filtration through a membrane immobilized with hapten.
• Measurement of retained enzyme activity on the membrane, which is inversely proportional to analyte concentration.

Main Results:

• The developed assay demonstrates high precision with a coefficient of variation of less than 5%.
• The assay provides rapid results, with a total test time of approximately 2 minutes.
• The method is effective for the quantification of theophylline, digoxin, and phenobarbital.

Conclusions:

• A novel, rapid, and precise immunometric assay has been successfully developed for determining hapten concentrations.
• This assay offers a significant improvement in speed and simplicity for therapeutic drug monitoring.
• The method holds potential for widespread clinical application in drug level determination.